Greetings all!
I was diagnosed back in late 2018 and have been on a W+W approach till mid-this year when my doctor suggested we start looking at treatment due to my lymphocyte count (just under 400). Thankfully, other than a slowly progressive increase in fatigue there haven't been any visible symptoms.
After considering the viable options based on the cytogenetics, we are going with an Obinutuzumab & Venetoclax one-year treatment plan. My doctor initially had me take a low dose of (50% normal) Chlorambucil for a few weeks to bring down the lymphocyte count into the low 100s.
I have had my first two weeks of Obin (100/900 mg & 1000 mg) and had a question which I haven't been able to find answered online anywhere else.
After the first week of the Obin infusion, my CBC differential showed that my lymphocyte count was below normal (for the first time in over five years) along with neutrophils and monocyte reduction below the lower level of the range.
Given this, what would be the reason to have to continue the infusions for the remainder of Cycle 1 and later the monthly Cycle 2-6 instances? Wouldn't that just end up further pushing me into cytopenia?
Thanks!
Kiron